SLC6A4 and neoplasm: Our study identified tumor-infiltrating CD8 T cells as the primary producers and mediators of a local, immunomodulatory serotonin axis independent of the gut, providing a working model in which SERT-regulated intratumoral serotonin modulates CD8 T cell immunity within the TME.